Federal contract award
75N93024F00006
TASK A02 - UNIVERSITY OF TEXAS MEDICAL BRANCH (UTMB)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | 75N93024D00042 |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $2.6M |
| Current contract value | $2.6M |
| Potential contract value / ceiling | $5.1M |
| Start date | Sep 20, 2024 |
| Current end date | Feb 17, 2027 |
| Potential end date | Feb 17, 2027 |
| Latest award activity | Aug 13, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 13, 2026 | P00009 | $240.3K | TASK A02 - DEVELOPMENT OF SMALL ANIMAL LASSA VIRUS INFECTION MODEL FOR THE ASSESSMENT OF ANTI-VIRAL ACTIVITY FOR MEDICAL COUNTERMEASURES EFFICACY |
| Jun 16, 2026 | P00008 | $732.1K | TASK A02 - DEVELOPMENT OF SMALL ANIMAL LASSA VIRUS INFECTION MODEL FOR THE ASSESSMENT OF ANTI-VIRAL ACTIVITY FOR MEDICAL COUNTERMEASURES EFFICACY |
| Feb 24, 2026 | P00007 | $380.2K | TASK A02 - DEVELOPMENT OF SMALL ANIMAL LASSA VIRUS INFECTION MODEL FOR THE ASSESSMENT OF ANTI-VIRAL ACTIVITY FOR MEDICAL COUNTERMEASURES EFFICACY |
| Jan 30, 2026 | P00006 | $88.5K | TASK A02 - DEVELOPMENT OF SMALL ANIMAL LASSA VIRUS INFECTION MODEL FOR THE ASSESSMENT OF ANTI-VIRAL ACTIVITY FOR MEDICAL COUNTERMEASURES EFFICACY |
| Dec 18, 2025 | P00005 | $0 | TASK A02 - DEVELOPMENT OF SMALL ANIMAL LASSA VIRUS INFECTION MODEL FOR THE ASSESSMENT OF ANTI-VIRAL ACTIVITY FOR MEDICAL COUNTERMEASURES EFFICACY |
| Jul 25, 2025 | P00004 | $0 | TASK A02 - DEVELOPMENT OF SMALL ANIMAL LASSA VIRUS INFECTION MODEL FOR THE ASSESSMENT OF ANTI-VIRAL ACTIVITY FOR MEDICAL COUNTERMEASURES EFFICACY |
| May 6, 2025 | P00003 | $0 | TASK A02 - DEVELOPMENT OF SMALL ANIMAL LASSA VIRUS INFECTION MODEL FOR THE ASSESSMENT OF ANTI-VIRAL ACTIVITY FOR MEDICAL COUNTERMEASURES EFFICACY |
| Mar 20, 2025 | P00002 | $0 | TASK A02 - DEVELOPMENT OF SMALL ANIMAL LASSA VIRUS INFECTION MODEL FOR THE ASSESSMENT OF ANTI-VIRAL ACTIVITY FOR MEDICAL COUNTERMEASURES EFFICACY |
| Nov 5, 2024 | P00001 | $151.8K | TASK A02 - EXERCISE OPTION 3A |
| Sep 20, 2024 | 0 | $1.0M | TASK A02 - UNIVERSITY OF TEXAS MEDICAL BRANCH (UTMB) |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2027-02-17 (108 days from calculation)
- +35 points
- 157 historical awards in this buyer and category group
- +15 points
- 10 recorded award transactions
- +10 points
- Latest award action: 2026-08-13
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.